Literature DB >> 8166738

Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction.

S A Sudjarwo1, M Hori, T Tanaka, Y Matsuda, T Okada, H Karaki.   

Abstract

In rabbit saphenous vein, endothelin (ET)-1 and ET-3 induced sustained contractions whereas the selective agonists of the ETB receptor, sarafotoxin S6c (STXc) and IRL 1620, induced transient contractions. In the presence of an ETA antagonist, BQ-123, contractions induced by ET-1, STXc and IRL 1620 did not change whereas ET-3 induced only transient contraction. The ETB antagonists, RES-701-1 and IRL 1038, only weakly antagonized the effects of these stimulants. In the muscle pretreated with STXc, neither STXc nor IRL 1620 was effective whereas ET-3 induced sustained contraction at higher concentrations than ET-1. In the muscle pretreated with STXc, BQ-123 weakly antagonized the effect of ET-1 and abolished the effect of ET-3. These results suggest that there are two types of ET receptors; less tachyphylactic and isopeptide-selective ETA receptor, and tachyphylactic and isopeptide-nonselective ETB receptor. The ETA receptors may be further classified as a BQ-123-sensitive ETA1 and a BQ-123-insensitive ETA2 subtypes. The ETB receptors may also be subclassified as the ETB1 and ETB2 subtypes based on the sensitivity to the ETB antagonists.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166738     DOI: 10.1006/bbrc.1994.1494

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors.

Authors:  M Adner; N Shankley; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Evidence for two endothelin Et(A) receptor subtypes in rabbit arteriolar smooth muscle.

Authors:  T M Curtis; C N Scholfield
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Pharmacological characteristics of endothelin receptors in the rabbit ventricular myocardium: the nonselective endothelin receptor antagonist PD 145065 antagonizes the positive inotropic effect of endothelin-3 but not of endothelin-1.

Authors:  I Norota; M Endoh
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

4.  Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract.

Authors:  J Latifpour; Y Fukumoto; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

5.  ETB-type receptors mediate endothelin-stimulated contraction in the aortic vascular smooth muscle of the spiny dogfish shark, Squalus acanthias.

Authors:  D H Evans; M Gunderson; C Cegelis
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

6.  Endothelin-induced electrical activity and calcium dynamics in vascular smooth muscle cells: a model study.

Authors:  A Y Wong; G A Klassen
Journal:  Ann Biomed Eng       Date:  1996 Sep-Oct       Impact factor: 3.934

7.  Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation.

Authors:  R Owe-Young; C G Schyvens; R A Qasabian; A D Conigrave; P S Macdonald; D J Williamson
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

8.  Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein.

Authors:  Nathan R Tykocki; Cheryl E Gariepy; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2009-03-18       Impact factor: 4.030

9.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.

Authors:  Akira Sato; Keiichi Ebina
Journal:  Inflamm Res       Date:  2013-01-31       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.